Patents Represented by Attorney Mary E. VanAtten
  • Patent number: 6140320
    Abstract: The present invention relates to benzoxazepinones of formula I: ##STR1## or stereoisomeric forms or mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same and methods of using the same for treating viral infection or as an assay standard or reagent.
    Type: Grant
    Filed: September 1, 1998
    Date of Patent: October 31, 2000
    Assignee: Dupont Pharmaceuticals Company
    Inventors: Anthony J. Cocuzza, James D. Rodgers